MYR 0.08
(7.14%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 38.33 Million MYR | -61.41% |
2022 | 99.33 Million MYR | -63.12% |
2021 | 269.3 Million MYR | 60.7% |
2020 | 167.58 Million MYR | 72.13% |
2019 | 97.35 Million MYR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2023 Q2 | 15.37 Million MYR | -4.19% |
2023 Q1 | 16.04 Million MYR | 22495.77% |
2023 Q4 | 3.64 Million MYR | 11.04% |
2023 Q3 | 3.27 Million MYR | -78.67% |
2022 Q2 | 19.45 Million MYR | -29.14% |
2022 Q1 | 27.44 Million MYR | 0.0% |
2022 FY | 99.33 Million MYR | -63.12% |
2022 Q4 | 71 Thousand MYR | -99.3% |
2022 Q3 | 10.08 Million MYR | -48.15% |
2021 FY | 269.3 Million MYR | 60.7% |
2020 FY | 167.58 Million MYR | 72.13% |
2019 FY | 97.35 Million MYR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
QES Group Berhad | 240.66 Million MYR | 84.073% |
Optimax Holdings Berhad | 114.11 Million MYR | 66.41% |
Pharmaniaga Berhad | 3.4 Billion MYR | 98.874% |
Apex Healthcare Berhad | 936.16 Million MYR | 95.906% |